References

European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer

10.1016/s1470-2045(21)00539-8 · 2022 · External reference

GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer

10.5306/wjco.v13.i4.237 · 2022 · External reference

Hypofractionated radiotherapy in localized, low-intermediate-risk prostate cancer: current and future prospectives

2023 · External reference

Hypofractionation and stereotactic body radiation therapy in inoperable locally advanced non-small cell lung cancer

10.18053/jctres.07.202102.017 · 2021 · External reference

How low can you go? The radiobiology of hypofractionation

10.1016/j.clon.2022.02.009 · 2022 · External reference

Thoracic reirradiation for lung cancer: a literature review and practical guide

2014 · External reference

Moderately hypofractionated radio(chemo)therapy with simultaneous integrated boost for recurrent, previously irradiated, high-grade glioma

10.21873/anticanres.16377 · 2023 · External reference

Volume, dose, and fractionation considerations for IMRT-based reirradiation in head and neck cancer: a multi-institution analysis

10.1016/j.ijrobp.2017.11.036 · 2018 · External reference

Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

10.1016/s0140-6736(23)00269-6 · 2023 · External reference

Hypofractionated proton therapy for benign tumors of the central nervous system: a systematic review of the literature

10.1016/j.critrevonc.2023.104114 · 2023 · External reference

Hypofractionated proton therapy for non-small cell lung cancer: ready for prime time? A systematic review and meta-analysis

10.1016/j.ctrv.2022.102464 · 2022 · External reference

Hypofractionated proton therapy in breast cancer: Where are we? A critical review of the literature

10.1007/s10549-022-06516-4 · 2022 · External reference

The role of hypofractionation in proton therapy

10.3390/cancers14092271 · 2022 · External reference

5-years analysis of effectivity and toxicity of ultra-hypofractionated proton radiotherapy in the treatment of low- and intermediate-risk prostate cancer-a retrospective analysis

10.3390/cancers15184571 · 2023 · External reference

Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation

10.1016/j.radonc.2017.08.005 · 2017 · External reference

Proton reirradiation: expert recommendations for reducing toxicities and offering new chances of cure in patients with challenging recurrence malignancies

10.1016/j.semradonc.2020.02.007 · 2020 · External reference

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

10.1136/bmj.b2700 · 2009 · External reference

Proton re-irradiation of unresectable recurrent head and neck cancers

10.5603/rpor.a2021.0029 · 2021 · External reference

The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine

10.1186/s13014-019-1407-9 · 2019 · External reference

Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy

10.1007/s00066-017-1129-6 · 2017 · External reference

Comparison of re-irradiation outcomes for charged particle radiotherapy and robotic stereotactic radiotherapy using CyberKnife for recurrent head and neck cancers: a multi-institutional matched-cohort analysis

10.21873/anticanres.11132 · 2016 · External reference

Re-irradiation with Moderate hypo-fractionation using intensity modulated photon or proton radiation therapy in locally recurrent squamous cell carcinoma of nasopharynx

10.4143/crt.2020.1349 · 2022 · External reference

Clinical outcomes of patients with recurrent lung cancer reirradiated with proton therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies

10.1016/j.prro.2019.02.008 · 2019 · External reference

Toxicity of proton therapy versus photon therapy on salvage re-irradiation for non-small cell lung cancer

10.3390/life12020292 · 2022 · External reference

Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era

10.3389/fonc.2022.1074675 · 2023 · External reference

Repeated proton beam therapy for hepatocellular carcinoma

10.1016/j.ijrobp.2005.11.043 · 2006 · External reference

Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma

10.1016/j.radonc.2017.03.004 · 2017 · External reference

Particle beam therapy for pelvic recurrence of colorectal cancer: a registry data analysis in Japan and a systematic review

10.1093/jrr/rrad024 · 2023 · External reference

Conservation treatment of the eye: conformal proton reirradiation for recurrent uveal melanoma

10.1016/j.ijrobp.2005.09.035 · 2006 · External reference

Uveal Melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation

10.1016/j.ijrobp.2009.12.018 · 2011 · External reference

Salvage proton beam therapy in local recurrent uveal melanoma

10.1016/j.ajo.2014.07.013 · 2014 · External reference

Proton re-irradiation of unresectable recurrent brain gliomas: clinical outcomes and toxicity

2021 · External reference

Clinical outcomes in patients with recurrent glioblastoma treated with proton beam therapy reirradiation: analysis of the Multi-Institutional Proton Collaborative Group Registry

10.1016/j.adro.2020.03.022 · 2020 · External reference

European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making

10.1016/s1470-2045(22)00447-8 · 2022 · External reference

The tolerance of primate spinal cord to re-irradiation

10.1016/0360-3016(93)90067-6 · 1993 · External reference

Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: a multi-institutional matched-cohort analysis

10.1016/j.radonc.2015.02.021 · 2015 · External reference

Carotid dosimetry and the risk of carotid blowout syndrome after reirradiation with head and neck stereotactic body radiation therapy

10.1016/j.ijrobp.2017.11.045 · 2018 · External reference

A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers

10.1186/1748-717x-8-242 · 2013 · External reference

Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer

10.1016/j.radonc.2013.08.012 · 2013 · External reference

Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a phase 2, single-center, randomized controlled trial

10.1002/cncr.28934 · 2014 · External reference

Carotid blowout syndrome after reirradiation for head and neck malignancies: a comprehensive systematic review for a pragmatic multidisciplinary approach

10.1016/j.critrevonc.2020.103088 · 2020 · External reference

Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy

2015 · External reference

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

10.1200/jco.2006.07.5937 · 2006 · External reference

Stereotactic body radiotherapy for ultra-central lung tumors: a systematic review and meta-analysis and International Stereotactic Radiosurgery Society practice guidelines

10.1016/j.lungcan.2023.107281 · 2023 · External reference

Ultra-central thoracic re-irradiation using 10-fraction stereotactic body radiotherapy for recurrent non–small-cell lung cancer tumors: preliminary toxicity and efficacy outcomes

10.1016/j.cllc.2020.05.010 · 2021 · External reference

Effectiveness and safety of reirradiation with stereotactic ablative radiotherapy of lung cancer after a first course of thoracic radiation: a meta-analysis

10.1097/coc.0000000000000709 · 2020 · External reference

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial

10.1016/s0140-6736(09)60484-0 · 2009 · External reference

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer

10.1056/nejmoa010580 · 2001 · External reference

Impact of recurrence and salvage surgery on survival after multidisciplinary treatment of rectal cancer

10.1200/jco.2016.72.1464 · 2017 · External reference

Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer

10.1111/j.1463-1318.2012.03005.x · 2012 · External reference

Feasibility of reirradiation in the treatment of locally recurrent rectal cancer

10.1002/bjs.9569 · 2014 · External reference

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study

10.1016/j.ijrobp.2005.09.017 · 2006 · External reference

Reirradiation of locally recurrent rectal cancer: a systematic review

10.1016/j.radonc.2014.11.021 · 2014 · External reference

Improved survival with preoperative radiotherapy in resectable rectal cancer

10.1056/nejm199704033361402 · 1997 · External reference

Improved outcomes for responders after treatment with induction chemotherapy and chemo(re)irradiation for locally recurrent rectal cancer

10.1245/s10434-020-08362-4 · 2020 · External reference

A multicentre retrospective review of SABR reirradiation in rectal cancer recurrence

10.1016/j.radonc.2021.06.030 · 2021 · External reference

Stereotactic body radiation therapy reirradiation for locally recurrent rectal cancer: outcomes and toxicity

10.1016/j.adro.2020.07.017 · 2020 · External reference

Radiotherapy & total neoadjuvant therapy for recurrent rectal cancer in previously irradiated patients, (RETRY): a multicenter prospective observational study

10.1186/s13014-024-02555-x · 2024 · External reference

Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): single institution experience and systematic literature review

10.5114/jcb.2019.82888 · 2019 · External reference

Reirradiation of the eye with plaque brachytherapy: a single institution experience report of eight consecutive patients submitted to retreatment after local relapse of malignant disease of the eye

10.1016/j.brachy.2013.10.007 · 2014 · External reference

Re-irradiation for recurrent primary brain tumors

10.21873/anticanres.11067 · 2016 · External reference

Re-irradiation in the brain: primary gliomas

10.1016/j.clon.2017.11.006 · 2018 · External reference

The evolving role of reirradiation in the management of recurrent brain tumors

10.1007/s11060-023-04407-2 · 2023 · External reference

Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol

10.1016/0360-3016(93)90428-x · 1993 · External reference

Tolerance of normal tissue to therapeutic irradiation

10.1016/0360-3016(91)90171-y · 1991 · External reference

Stereotactic body radiation therapy for hepatocellular carcinoma: meta-analysis and International Stereotactic Radiosurgery Society Practice Guidelines

2023 · External reference

An overview of stereotactic body radiation therapy for hepatocellular carcinoma

10.1080/17474124.2020.1744434 · 2020 · External reference

Repeated stereotactic body radiation therapy for hepatocellular carcinoma

10.1016/j.prro.2020.08.002 · 2021 · External reference

A multi-institutional retrospective study of repeated stereotactic body radiation therapy for intrahepatic recurrent hepatocellular carcinoma

10.1016/j.ijrobp.2020.07.034 · 2020 · External reference

Essential requirements for reporting radiation therapy in breast cancer clinical trials: an international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)

2023 · External reference

Radiotherapy treatment plannINg study Guidelines (RATING): a framework for setting up and reporting on scientific treatment planning studies

10.1016/j.radonc.2020.09.033 · 2020 · External reference

The lessons of QUANTEC: recommendations for reporting and gathering data on dose–volume dependencies of treatment outcome

10.1016/j.ijrobp.2009.08.074 · 2010 · External reference